Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/18/2010EP1874314B1 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
08/18/2010EP1858896B1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
08/18/2010EP1845978B1 Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1743633B1 Use of a combination of theanine and serotonin for sleep disorders
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010EP1735275B1 Aryl sulfones and uses related thereto
08/18/2010EP1723131B1 Crystalline polymorphs of a cxc-chemokine receptor ligand
08/18/2010EP1716162B1 Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
08/18/2010EP1709049B1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
08/18/2010EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/18/2010EP1682543B1 Methods for the production of novel tiotropium salts
08/18/2010EP1682523B1 Morpholine derivatives as norepinephrine reuptake inhibitors
08/18/2010EP1644005B1 Metabolite of quetiapine
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1530636B1 Treatment of melanoma by reduction in clusterin levels
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1443899B1 Bowel cleansing agent
08/18/2010EP1426380B1 Association compound of trehalose or maltitol with metal ion compound
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010EP1392321B1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
08/18/2010EP1351963B1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010EP1261616B1 Modified oligonucleotides for mismatch discrimination
08/18/2010EP1140009B2 Absorbent article composition and use thereof for sequestering skin irritants.
08/18/2010EP1121115B2 Pufa supplements
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010EP0910246B1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN1993352B Piperazine derivatives with CCR3 inhibiting activity
08/18/2010CN1980647B Formulation comprising histone deacetylase inhibitor
08/18/2010CN1922182B Pyrrolotriazine compounds as kinase inhibitors
08/18/2010CN1837202B Flavonols with blood-fat-lowering effect
08/18/2010CN1835752B Multivitamin syrup for children or young adults
08/18/2010CN1830960B 10-phenyl hydroisoindolone type compounds, preparation method and use thereof
08/18/2010CN1823803B Erigeron breviscapus injection preparation and its preparation method
08/18/2010CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors
08/18/2010CN1732926B Medicine contained soft capsule
08/18/2010CN1726039B Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
08/18/2010CN1720250B Solid-phase saccharide sensing compounds
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN1686089B Xylitol granule capable of directly being pressed into tablet and its preparation method
08/18/2010CN101809443A Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
08/18/2010CN101809039A Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
08/18/2010CN101809026A 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a derivatives and their use for the treatment of malaria
08/18/2010CN101809021A octahydro-pyrrolo[3,4-b]pyrrole n-oxides
08/18/2010CN101809020A Perharidines as CDK inhibitors
08/18/2010CN101809019A Gamma secretase modulators
08/18/2010CN101809018A solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
08/18/2010CN101809017A phthalazinone derivatives
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101809015A Salts of a CGRP antagonist, method for producing the same and use thereof as drugs
08/18/2010CN101809012A Spiro substituted compounds as angiogenesis inhibitors
08/18/2010CN101809009A New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
08/18/2010CN101809008A Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
08/18/2010CN101809007A Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours
08/18/2010CN101809005A Fused bicyclic compound
08/18/2010CN101809004A Naphthalene isoxazoline compounds for control of invertebrate pests
08/18/2010CN101809002A morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101809000A Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
08/18/2010CN101808999A Quinoline derivatives as 5HT5A receptor antagonists
08/18/2010CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808990A Piperidine derivatives as modulators of chemokine receptor activity
08/18/2010CN101808987A New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101808666A Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
08/18/2010CN101808654A Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
08/18/2010CN101808653A Plant extract and use thereof
08/18/2010CN101808651A polymer conjugate of steroid
08/18/2010CN101808650A Composition and treatment
08/18/2010CN101808649A Micro-RNAs that control myosin expression and myofiber identity
08/18/2010CN101808648A Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma
08/18/2010CN101808647A Methods of treating cognitive disorders by inhibition of Gpr12
08/18/2010CN101808646A Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/18/2010CN101808645A improved brimonidine compositions for treating erythema
08/18/2010CN101808644A Polymerase inhibitors and the use thereof for the treatment of tumors
08/18/2010CN101808643A Preparation for the treatment of equine laminitis
08/18/2010CN101808642A Mast cell stabilizers in the treatment of obesity
08/18/2010CN101808641A gel containing pirfenidone
08/18/2010CN101808640A Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism
08/18/2010CN101808639A Antifungal pharmaceutical composition
08/18/2010CN101808638A Antifungal composition
08/18/2010CN101808637A Pharmaceutical composition
08/18/2010CN101808636A Treatment of melanoma
08/18/2010CN101808635A Use of piperine and derivatives thereof for the therapy of neurological conditions
08/18/2010CN101808634A epoxide inhibitors of cysteine proteases
08/18/2010CN101808633A Edible fat composition for enhancing bone strength
08/18/2010CN101808632A Controlled release tamsulosin hydrochloride tablets and a process of making them
08/18/2010CN101808631A galenical formulations of organic compounds
08/18/2010CN101808630A galenical formulations of organic compounds
08/18/2010CN101808629A Method for activating regulatory T-cells
08/18/2010CN101808628A Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient
08/18/2010CN101808627A antiseptics
1 ... 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 ... 7860